Literature DB >> 11804483

Erythropoietin mimetics derived from solution phase combinatorial libraries.

Joel Goldberg1, Qing Jin, Yves Ambroise, Shigeki Satoh, Joel Desharnais, Kevin Capps, Dale L Boger.   

Abstract

The erythropoietin receptor (EPOr) is activated by ligand-induced homodimerization, which leads to the proliferation and differentiation of erythroid progenitors. Through the screening of combinatorial libraries of dimeric iminodiacetic acid diamides, novel small molecule binders of EPOr were identified in a protein binding assay. Evaluation of a series of analogues led to optimization of binding subunits, and these were utilized in the synthesis of higher order dimer, trimer, and tetramer libraries. Several of the most active EPOr binders were found to be partial agonists and induced concentration-dependent proliferation of an EPO-dependent cell line (UT-7/EPO) while having no effect on a cell line lacking the EPOr (FDC-P1). An additional compound library, based on a symmetrical isoindoline-5,6-dicarboxylic acid template and including the optimized binding subunits, was synthesized and screened leading to the identification of additional EPO mimetics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804483     DOI: 10.1021/ja0118789

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

Review 1.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

2.  Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library.

Authors:  Landon R Whitby; Kristopher E Boyle; Lifeng Cai; Xiaoqian Yu; Miriam Gochin; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2012-03-03       Impact factor: 2.823

3.  Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions.

Authors:  Landon R Whitby; Yoshio Ando; Vincent Setola; Peter K Vogt; Bryan L Roth; Dale L Boger
Journal:  J Am Chem Soc       Date:  2011-06-15       Impact factor: 15.419

4.  Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.

Authors:  Ying Wang; Lijing Su; Matthew D Morin; Brian T Jones; Yuto Mifune; Hexin Shi; Kuan-Wen Wang; Xiaoming Zhan; Aijie Liu; Jianhui Wang; Xiaohong Li; Miao Tang; Sara Ludwig; Sara Hildebrand; Kejin Zhou; Daniel J Siegwart; Eva Marie Y Moresco; Hong Zhang; Dale L Boger; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

5.  Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.

Authors:  Lijing Su; Ying Wang; Junmei Wang; Yuto Mifune; Matthew D Morin; Brian T Jones; Eva Marie Y Moresco; Dale L Boger; Bruce Beutler; Hong Zhang
Journal:  J Med Chem       Date:  2019-03-13       Impact factor: 7.446

6.  NMR characterization of interleukin-2 in complexes with the IL-2Ralpha receptor component, and with low molecular weight compounds that inhibit the IL-2/IL-Ralpha interaction.

Authors:  S Donald Emerson; Robert Palermo; Chao-Min Liu; Jefferson W Tilley; Li Chen; Waleed Danho; Vincent S Madison; David N Greeley; Grace Ju; David C Fry
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

7.  Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.

Authors:  Matthew D Morin; Ying Wang; Brian T Jones; Yuto Mifune; Lijing Su; Hexin Shi; Eva Marie Y Moresco; Hong Zhang; Bruce Beutler; Dale L Boger
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

Review 8.  Understanding cytokine and growth factor receptor activation mechanisms.

Authors:  Mariya Atanasova; Adrian Whitty
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

9.  Discovery libraries targeting the major enzyme classes: the serine hydrolases.

Authors:  Katerina Otrubova; Venkat Srinivasan; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

10.  Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.

Authors:  Andrew M Lee; Jillian M Rojek; Christina F Spiropoulou; Anette T Gundersen; Wei Jin; Alex Shaginian; Joanne York; Jack H Nunberg; Dale L Boger; Michael B A Oldstone; Stefan Kunz
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.